News Image

INSULET CORP (NASDAQ:PODD) is a candidate for growth investors. Here's why.

By Mill Chart

Last update: Jan 10, 2024

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if INSULET CORP (NASDAQ:PODD) is suited for growth investing. Investors should of course do their own research, but we spotted INSULET CORP showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

Why NASDAQ:PODD may be interesting for growth investors.

  • INSULET CORP demonstrates a strong Return on Equity(ROE) of 19.75%. This indicates the company's ability to generate favorable returns for shareholders and reflects its efficient utilization of capital. INSULET CORP shows promising potential for continued success.
  • INSULET CORP has consistently exceeded EPS estimates in the last 4 quarters, demonstrating its ability to outperform market expectations. This trend highlights the company's strong financial performance and its potential for future growth.
  • INSULET CORP has demonstrated strong 1-year revenue growth of 25.23%, reflecting revenue momentum and its ability to generate consistent top-line expansion. This growth underscores the company's strong market position and its potential for future success.
  • With consistent quarter-to-quarter (Q2Q) revenue growth of 26.97%, INSULET CORP exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for continued growth.
  • With a favorable trend in its operating margin over the past year, INSULET CORP demonstrates its ability to enhance profitability through efficient operations. This growth reflects the company's focus on optimizing its cost structure.
  • INSULET CORP has shown positive growth in its free cash flow (FCF) over the past year, indicating improved cash generation and financial strength. This growth highlights the company's ability to effectively manage its cash flows and generate surplus funds.
  • INSULET CORP has demonstrated consistent growth in its earnings per share (EPS) from one quarter to another (Q2Q), with a 103.0% increase. This indicates improving financial performance and the company's effective management of its operations.
  • Analysts' average next Quarter EPS Estimate for INSULET CORP has witnessed a 7.16% change in the last 3 months, underscoring the dynamic nature of market sentiment towards the company's EPS prospects.
  • The recent financial report of INSULET CORP demonstrates a 103.0% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
  • The earnings per share (EPS) growth of INSULET CORP are accelerating: the current Q2Q growth of 103.0% is above the previous year Q2Q growth of 94.44%. Earnings momentum and acceleration are key for high growth systems.

What is the full fundamental picture of NASDAQ:PODD telling us.

At ChartMill, a crucial aspect of their analysis is the assignment of a Fundamental Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous fundamental indicators and properties.

PODD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 201 industry peers in the Health Care Equipment & Supplies industry. While PODD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PODD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!

Our latest full fundamental report of PODD contains the most current fundamental analsysis.

More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

INSULET CORP

NASDAQ:PODD (4/22/2024, 7:22:15 PM)

After market: 164.42 0 (0%)

164.42

-1.83 (-1.1%)

PODD News

News Image6 days ago - InvestorPlace3 Weight-Loss ETFs to Profit From the Obesity Drug Boom

Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.

News Image8 days ago - InvestorPlace7 Stable Stocks for 50% Returns by Early 2025

These 7 stable stocks also offer 50% returns according to analysts according to analysts tasked with following their respective industries.

News Image14 days ago - ChartmillWhich S&P500 stocks are moving on Tuesday?

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

News Image14 days ago - ChartmillTop S&P500 movers in Tuesday's session

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

News Image18 days ago - ChartmillWhy NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.

INSULET CORP (NASDAQ:PODD)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

News Image20 days ago - Insulet CorporationInsulet to Announce First Quarter 2024 Financial Results on May 9, 2024
News Imagea month ago - Market News VideoWednesday Sector Laggards: Healthcare, Utilities
News Imagea month ago - Insulet CorporationInsulet Appoints Ana Maria Chadwick as Chief Financial Officer
News Imagea month ago - Market News VideoTuesday Sector Laggards: Technology & Communications, Healthcare
News Imagea month ago - Market News VideoWednesday Sector Laggards: Technology & Communications, Healthcare
News Imagea month ago - Market News VideoPODD July 2025 Options Begin Trading
News Image2 months ago - Insulet CorporationInsulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy
PODD Links
Follow us for more